Sudden cardiac death: Epidemiologic and financial worldwide perspective

Journal of Interventional Cardiac Electrophysiology

Volumn 17, Issue 3, 2006, Pages 199-203

  Smith, Timothy W ^a   Cain, Michael E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arrhythmia; ICD; Sudden cardiac death

Indexed keywords

AMIODARONE;

CARDIOVASCULAR RISK; CAUSE OF DEATH; COMORBIDITY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEART VENTRICLE ARRHYTHMIA; HUMAN; INCIDENCE; MORTALITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SUDDEN DEATH;

COST CONTROL; COST-BENEFIT ANALYSIS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; INCIDENCE; RISK ASSESSMENT; WORLD HEALTH;

EID: 34247269711     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-006-9069-6     Document Type: Review

References (36)

1. Myerburg, R. J., & Wellens, H. J. J. (2006). Chapter 1: Epidemiology of cardiac arrest. In S. G. Priori & D. P. Zipes (Eds.). Sudden cardiac death: A handbook for clinical practice (pp. 3-20). Oxford, UK: Blackwell.
2. Zheng, Z.-J., Croft, J., Giles, W. H., & Mensah, G. A. (2001). Sudden cardiac death in the United States, 1989 to 1998. Circulation, 104, 2158-2213.
3. Gottlieb, C. D. (1997). Dead is dead - artificial substitutions are no substitute. Lancet, 349, 662-663.
4. Myerburg, R. J., Mitrani, R., Interian, Jr. A., & Castellanos, A. (1998). Interpretation of outcomes of antiarrhythmic clinical trials: Design features and population impact. Circulation, 97, 1514-1521.
5. Myerburg, R. J., Kessler, K. M., & Castellanos, A. (1993). Sudden cardiac death: Epidemiology, transient risk, and intervention assessment. Annals of Internal Medicine, 119, 1187-1197.
6. Myerburg, R. J., Kessler, K. M., & Castellanos, A. (1992). Sudden cardiac death. structure, function, and time-dependence of risk. Circulation, 85(Supplement I), I2-I10.
7. Priori, S. G., Aliot, E., Blomstrom-Lundqvist, C., Bossaert, L., Breithardt, G., Brugada, P., et al. (2001). Task force on sudden cardiac death of the European Society of Cardiology. European Heart Journal, 22, 1374-1450.
8. de Vreede-Swagemakers, J. J. M., Gorgels, A. P. M., Dubois-Arbouw, W. I., van Ree, J. W., Daemen, M. J .A. P., Houben, L. G. E., et al. (1997). Out-of-hospital cardiac arrest in the 1990s: A population-based study in the Maastricht area on incidence, characteristics and survival. Journal of the American College of Cardiology, 30(6), 1500.
9. Kawakubo, K., & Lee, J. S. (2005). [Incidence rate of sudden death in Japan][Japanese]. Japanese Journal of Clinical Medicine, 36(7), 1127-1134.
10. Kawamura, T., Kondo, H., Hirai, M., Wakai, K., Tamakoshi, A., Terazawa, T., et al. (1999). Sudden death in the working population; a collaborative study in Central Japan. European Heart Journal, 20(5), 338-343.
11. Toyoshima, H., Hayashi, S., Tanabe, N., Satoh, T., Aizawa, Y., Izumi, T. (1996). Sudden death of adults in Japan. Nagoya Journal of Medical Science, 59(3-4), 81-95.
12. Aizaki, T., Izumi, T., Kurosawa, T., Shoi, N., Furukawa, M., & Kurihara, K. (1997). Sudden cardaic death in Japanese people aged 20-60 years - an autopsy study of 133 cases. Japanese Circulation Journal, 61(12), 1004-1010.
13. Chugh, S. s., Jui, J., Gunson, K., Stecker, E. C., John, B. T., Thompson, B., et al. (2004). Current burden of sudden cardiac death: Mulitple source surveillance versus retrospective death certificate-base review in a large U.S. community. Journal of the American College of Cardiology, 44(6), 1268-1275.
14. Smith, T. W., & Cain, M. E. (2006). Chapter 14: Pharmacology of sudden death. In S. G. Priori & D. P. Zipes (Eds.), Sudden cardiac death: A handbook for clinical practice (pp. 205-219). Oxford, UK: Blackwell.
15. Huikuri, H. V., Castellanos, A., & Myerburg, R. J. (2001). Sudden death due to cardiac arrhythmias. New England Journal of Medicine, 345(20), 1473-1482.
16. The CASCADE Investigators. (1993). Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (The CASCADE Study). American Journal of Cardiology, 72, 280-287.
17. Connolly, S. J., Gent, M., S. R. R., Dorian, P., Roy, D., Sheldon, R. S., et al. (2001). Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable defibrillator against amiodarone. Circulation, 101, 1297-1302.
18. Kuck, K.-H., Cappato, R., Siebels, J., Ruppel, R., & Investigators ftC. (2000). Randomized comparison of antiarrhythmic drug therapy with impoantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation, 102, 748-754.
19. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. (1997). A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. New England Journal of Medicine, 337(22), 1576-1583.
20. Buxton, A. E., Fisher, J. D., Josephson, M. E., Lee, K. L., Pryor, D. B., Prystowsky, E. N., et al. (1993). Prevention of sudden death in patients with coronary artery disease: The Multicenter Unsustained Tachycardia Trial (MUSTT). Progress in Cardiovascular Disease, 36(3), 215-226.
21. Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., et al. (1996). Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. New England Journal of Medicine, 335(26), 1933-1940.
22. Moss, A. J., Zareba, W., Hall,W. J., Klein, H., Wilber, D. J., Cannom, D. S., et al. (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New England Journal of Medicine, 346(12), 877-883.
23. Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., et al. (2005). Amiodarone or an implantable cardioverter- defibrillator for congestive heart failure. New England Journal of Medicine, 352(3), 225-237.
24. Mark, D. B., & Hlatky, M. A. (2002). Medical economics and the assessment of value in cardiovascular medicine: Part I. Circulation, 106, 516-520.
25. Mark, D. B., Nelson, C. L., J. A. K., Al-Khatib, S. M., Tsiatis, A. A., Cowper, P. A., et al. (2006). Cost-effectiveness of defibrillator therapy of amiodarone in chronic stable heart failure: Results from the Sudden Death in Heart Failure Trial (SCD-HeFT). Circulation, 114, 135-142.
26. Sanders, G. D., Hlatky, M. A., & Owens, D. K. (2005). Cost-effectiveness of implantable cardioverter-defibrillators. New England Jounal of Medicine, 353, 1471-1480.
27. Zwanziger, J., Hall, W. J., Dick, A. W., Zhao, H., Mushlin, A. I., Hahn, R. M., et al. (2006). The cost effectiveness of implantable cardiovertor- defibrillators: Results From the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. Journal of the American College of Cardiology, 47, 2310-2318.
28. Stevenson, L. W. (2006). Implantable cardioverter-defibrillators for primary prevention of sudden death in heart failure: Are there enough bangs for the bucks? Circulation, 114, 101-103.
29. Hauser, R. G. (2006). The growing mismatch between patient longevity and the service life of implantable cardioverterdefibrillators. Journal of the American College of Cardiology, 45, 2022-2025.
30. Reynolds, M. R., Cohen, D. J., Kugelmass, A. D., Brown, P. P., Becker, E. R., Culler, S. D., et al. (2006). The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. Journal of the American College of Cardiology, 47, 2493-2497.
31. Meier, B. (2006). Growing debate as doctors train on new devices. New York Times 2006 August 1.
32. Camm, A. J., & Nisam, S. (2000). The utilization of the implantable defibrillator-a European enigma. European Heart Journal, 21, 1998-2001.
33. Camm, A. J., Klein, H., & Nisam, S. (2006). The cost of implantable defibrillators: Perceptions and reality. European Heart Journal (in press) DOI 10.1093/eurheartj/ehl166.
34. Chan, P. S., Stein, K., Chow, T., Fendrick, M., Bigger, J. T., & Vijan, S. (2006). Cost-effectiveness of a microvolt T-Wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population. Journal of the American College of Cardiology, 48, 112-121.
35. Cuculich, P. S., Sanchez, J. M., Kerzner, R., Greenberg, S. L., Chen, J., Faddis, M. N., et al. (2006). Is there a role for implantable cardioverter-defibrillator therapy for the primary prevention of sudden death in patients with chronic kidney disease [Abstract]. Journal of the American College of Cardiology, 47(Suppl. A), 19A.
36. Sanchez, J. M., Kerzner, R., Greenberg, S. L., Chen, J., Faddis, M. N., Gleva, M. J., et al. (2006). Charlson comorbidity index predicts early mortality among ICD patients [Abstract]. Circulation, 114 (Suppl. II), II-468.